| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Insulin Degludec |
| Brand | Tresiba® |
| Indication | Treatment of diabetes mellitus |
| Assessment Process | |
| Rapid review commissioned | 17/12/2012 |
| Rapid review completed | 04/01/2013 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Recommended. |
| Full pharmacoeconomic assessment commissioned by HSE | 04/11/2014 |
| NCPE assessment completed | 04/05/2015 |
| NCPE assessment outcome | Reimbursement Not Recommended at the submitted price. |
December 2015
The HSE has approved reimbursement following confidential price negotiations.